NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹8.97 Cr | ₹28 Cr | ₹91 Cr | ₹75 Cr | ₹105 Cr |
What is the latest Contingent Liabilities ratio of NEULAND LABORATORIES ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹8.97 Cr |
Mar2024 | ₹28 Cr |
Mar2023 | ₹91 Cr |
Mar2022 | ₹75 Cr |
Mar2021 | ₹105 Cr |
How is Contingent Liabilities of NEULAND LABORATORIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹8.97 Cr | -67.65 | |
Mar2024 | ₹28 Cr | -69.60 | |
Mar2023 | ₹91 Cr | 22.14 | |
Mar2022 | ₹75 Cr | -28.68 | |
Mar2021 | ₹105 Cr | - |
Compare Contingent Liabilities of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹18,232.3 Cr | -2.5% | 16.4% | 70.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | -2.5% |
16.4% |
70.8% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses